Dietary magnesium intake and risk of hypertension in a Mexican adult population: a cohort study by Gerardo G Huitrón-Bravo et al.
Huitrón-Bravo et al. BMC Nutrition 2015, 1:6
http://www.biomedcentral.com/2055-0928/1/6RESEARCH ARTICLE Open AccessDietary magnesium intake and risk of
hypertension in a Mexican adult population:
a cohort study
Gerardo G Huitrón-Bravo1, Edgar Denova-Gutiérrez2,3*, José de Jesús Garduño-García4,5, Juan O Talavera6,
Benjamín Herreros7 and Jorge Salmerón2,8Abstract
Background: Hypertension is associated with increased risk of heart disease, stroke, kidney failure, premature
mortality, and disability. This rising prevalence of hypertension has been linked to insufficient dietary magnesium
intake. However, epidemiological evidence supporting this relationship is inconsistent. To investigate whether
magnesium intake affects blood pressure, we examined the association between dietary magnesium intake and the
incidence of hypertension in apparently healthy Mexican adults participating in the Health Workers Cohort Study.
Methods: A total of 1,378 subjects (77.4% women and 22.6% men), participating in the Health Workers Cohort Study,
free of hypertension at baseline (systolic blood pressure <140 mmHg or/and diastolic blood pressure <90 mmHg),
were prospectively studied. Magnesium intake was evaluated using a semi-quantitative food frequency questionnaire.
The longitudinal relationships between dietary magnesium intake and the incidence of hypertension were analyzed
with generalized estimation equations.
Results: During a median follow-up of 7 years, 16.4% of women and 31.9% of men developed incident hypertension.
After adjustment for age and sex, we found a trend of decreasing diastolic blood pressure with rising magnesium
intake, by tertiles (the coefficients were −0.75 mmHg [95% confidence interval (CI): −1.77, 0.27], −1.27 mmHg (95%
CI: −2.73, −0.02; P for trend = 0.01). This inverse association was attenuated after further adjustment for known risk
factors. In the fully adjusted model, magnesium intake was inversely associated, although not significantly, with the risk
of developing hypertension; subjects in the highest tertile of magnesium intake had a decreased risk for hypertension
(odds ratio 0.83, 95% CI: 0.49–1.39, P for trend = 0.48).
Conclusions: These results do not support the hypothesis that magnesium intake reduces the development of
hypertension, although a modest inverse association between magnesium consumption and lower blood pressure
cannot be ruled out.
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Elevated blood pressure (BP) or hypertension, defined as
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or/and diastolic blood pressure equal to or above
90 mmHg, is associated with increased risk of heart
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unless otherwise stated.disability [1]. Worldwide in 2008, approximately 40%
of adults older than 25 years had been diagnosed with
hypertension [1]. In the Americas, 35% of the adult
population suffers from this condition [2]. In Mexico,
according to the 2012 National Health and Nutrition
Survey [3], 32.4% of men and 32.3% of women had
hypertension. This rising prevalence of hypertension
is linked to population aging and to excess weight
and persistent stress exposure on the individual level.
Other causes of hypertension include, but are not
limited to, tobacco use, high consumption of alcohol,entral. This is an Open Access article distributed under the terms of the Creative
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intake of minerals like potassium, calcium, and magne-
sium (Mg) [4].
Mg plays an important role in cellular processes including
vascular tone, cardiac excitability, neuromuscular transmis-
sion, and blood pressure [5-7]; additionally, Mg could also
decrease BP, since as a calcium antagonist in smooth
muscle, it might produce vasorelaxation [8]. Moreover, Mg
diminishes the biological activities of angiotensin II and
inhibits norepinephrine release. It has also been reported
that plasma rennin activity is inversely associated with
serum Mg. Furthermore, it has been shown that variations
in extracellular Mg content modify the production
and release of nitric oxide, resulting in the alteration
of arterial smooth muscle tone. Finally, it also has been
reported that the antioxidant properties of magnesium
could attenuate the detrimental effects of oxidative stress
on the vasculature, thereby preventing increased vascular
tone and contractility [8,9].
Magnesium, a cofactor for hundreds of enzymes, is
an essential mineral that is crucial for a numerous of
metabolic functions in the human body. The main
dietary sources of Mg are whole grains, legumes,
nuts, and green leafy vegetables [10], while processed
and refined foods are poor Mg sources [11]. Low Mg
consumption is common worldwide (although statistics
do not exist for Mexico); in the US, 67% of women and
64% of men consume inadequate amounts of Mg [12].
Insufficient dietary Mg intake has been related to adverse
health outcomes including hypertension [13-15]. However,
epidemiological evidence supporting this relationship is
inconsistent. For the most part, cross-sectional studies
have demonstrated an inverse relationship between dietary
Mg and BP [16-19]. However, prospective cohort studies
have also found weak [20,21] or no relationships [22,23]
between Mg and the development of hypertension.
Clinical findings on this topic are mixed, including
reports that Mg supplementation lowers [24-26] or does
not affect [27] BP.
To investigate whether magnesium intake affects BP,
we examined the association between dietary magnesium
intake and the incidence of hypertension in apparently




The HWCS is a longitudinal study investigating relation-
ships between lifestyle and health. From March 2004 to
April 2006, at baseline examination, it formally enrolled
8,307 medical, administrative, and academic employees
and their relatives from three different institutions: the
(i) Instituto Mexicano del Seguro Social (IMSS) and
(ii) Instituto Nacional de Salud Pública (INSP), bothlocated in Cuernavaca, Morelos State; and workers at
the (iii) Universidad Autónoma del Estado de México
(UAEM) in Toluca, Mexico State. The participants in this
cohort study are middle- to low-income status, residing in
urban central Mexico. Study methods and participants’
characteristics have been previously described [28,29].
Seven years later, approximately 2,500 subjects of
those original HWCS subjects were invited to participate
in a follow-up data collection phase, which took place from
2012–2013. Of these, only 1,855 participants attended the
second examination and were eligible for the current
investigation. Both the participants attending the second
examination and no participants in the follow-up study
were similar in age, percentage of women, and preva-
lence of diabetes. Data on sociodemographic, lifestyle, and
medical history factors was collected with self-administered
questionnaires, and anthropometric measurements and
clinical evaluations were performed. For the present
analysis of participants in both phases of the HWCS,
we excluded individuals with hypertension at base-
line (n = 286), which we defined as having systolic
blood pressure ≥140 mmHg or/and diastolic blood
pressure ≥90 mmHg, self-reported history of hyper-
tension, and history of anti-hypertensive treatment; in
addition, we eliminated subjects who responded to less
than 85% of questions or did not complete all the
diet-related questions (n = 150). We also used the
standard deviation method to exclude subjects providing
extreme caloric intake values (<600, >7,000 kcal/day)
(n = 25) and/or extreme magnesium consumption values
(n = 16) [30]. The final study population included 1,378
men and women without hypertension at baseline and
who had provided complete data on Mg intake and other
major lifestyle variables.
Ethics statement
This study was planned and performed according to the
guidelines of the Declaration of Helsinki. All participating
institutions’ research ethics committees (Comité de Ética
en Investigación, Instituto Mexicano del Seguro Social
(No. 12CEI 09 006 14); Comité de ética en Investigación,
Instituto Nacional de Salud Pública (No. 13CEI 17 007 36);
Comité de Ética, Centro de Investigación en Ciencias
Médicas (No. 1233008X0236)) approved the study protocol
and informed consent forms. Written informed consent
was obtained from all participants.
Assessment of magnesium intake
In the HWCS, a validated 116-item semi-quantitative
food frequency questionnaire (FFQ) was used to collect
dietary information [31]. On the FFQ, a common unit or
portion size for each food was specified and the participants
were asked how often they had consumed that amount on
average during the previous year. Ten possible responses
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recorded. Magnesium and other nutrient intakes were
computed by multiplying the frequency of consumption of
each unit of food from the FFQ by the magnesium and
nutrient content of the specified portion size. Composition
values for dietary magnesium and other nutrients were
obtained from a Mexican database of food contents
[32]. Information about use of specific brand and type
of multivitamins was collected by asking current users
about weekly number of multivitamins taken. Total
magnesium represented the sum of magnesium intake
from dietary and supplemental sources. Each nutrient
was adjusted for total energy using the residual method
[33]. Finally, in order to compute energy consumption,
the daily frequency of consumption of each food was
multiplied by the food’s energy content.
Assessment of anthropometric measures
Body weight was measured with a previously calibrated
electronic scale (model BC-533; Tanita, Tokyo, Japan),
with participants wearing minimal clothing and no shoes.
Height was measured using a conventional stadiometer
(SECA brand) on barefoot subjects standing with their
shoulders in a normal position; the measurements were
taken with a tape in a horizontal plane perpendicular to
the vertical scale, touching the top of the head at the
moment of inspiration. Body mass index (BMI) was
computed as a ratio of weight in kilograms divided by
the height in meters squared.
Assessment of hypertension
Subjects’ blood pressure was measured twice during
each study visit by a trained nurse using an automatic
monitor. The first measurement was taken after 5 min
of rest, while participants were sitting with the dominant
arm supported at heart level. The second measurement
was taken in the same way, 5 min after the first.
Incident hypertension was considered present if the
subject had received treatment for high blood pressure
and/or physician diagnosis (systolic blood pressure equal
to or above 140 mmHg or/and diastolic blood pressure
equal to or above 90 mmHg) in our cohort study.
All measurement procedures were performed by nurses
trained to use standardized procedures (reproducibility was
evaluated, resulting in concordance coefficients between
0.83 and 0.90).
Assessment of other variables
Information on participants’ sociodemographic cha-
racteristics (e.g., age, sex, and education), medical
history, and lifestyle, including alcohol and tobacco
consumption, were collected using a self-administered
questionnaire.Physical activity level was determined using a survey
in which participants reported the time they spent each
week on activities such as running and walking during a
typical week in the previous year. Each activity was given
a value in metabolic equivalent tasks (METs) and total
METs per week was computed.
Statistical analysis
A descriptive analysis of the main variables of interest
(age, BMI, waist circumference, physical activity, total
energy intake, etc.) across tertiles of total dietary magne-
sium intake was performed. Analysis of variance (ANOVA)
was used to evaluate mean differences across tertiles of total
dietary magnesium intake. The chi-square test was used to
determine differences in the distribution of qualitative
variables across tertiles of total dietary magnesium intake.
Longitudinal coefficients were calculated between
magnesium intake (tertiles) and systolic and diastolic
blood pressure using the generalized estimating equations
(GEE) technique [34]. This technique tests the relationship
between systolic and diastolic blood pressure and
magnesium intake at a specific time point, resulting
in a standardized regression coefficient which can be
interpreted as a longitudinal coefficient. This method
corrects for time-dependent covariates, like year of
measurement and biological age, and time-independent
covariates like sex. We also fitted GEE models to study
the association between magnesium intake and incident
hypertension. This approach enabled us to describe
time-dependent relationships between magnesium intake
and hypertension status (yes or no), after adjusting for
potential confounders. In each GEE model, we chose
“Logit” as the link function because hypertension status
was a binary dependent variable.
To compute regression coefficients and odds ratios
(ORs), we fitted four multivariate models. The first
model was adjusted for age and sex. The second model
added smoking (never, past, and current), physical activity
(METs per week), alcohol intake (non-drinker/drinker),
postmenopausal hormone use (yes/no), and use of
multivitamin supplements (yes/no). The third model
included additional adjustments for dietary intake of
saturated fat (g/day), cholesterol (mg/day), sodium
(mg/day), dietary glycemic load (quintiles), fiber (g/day),
and total energy intake (kcal/day). The final model
additionally controlled for body mass index (kg/m2),
history of diabetes mellitus (yes/no), and family history of
hypertension. Tests of linear trend across increasing
tertiles of magnesium intake were conducted by assigning
the means of intakes in tertiles, treated as a continuous
variable.
All P values presented are two sided; P < 0.05 was
considered statistically significant. The statistical analyses
were performed using the STATA statistical software
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College Station, TX).
Results
The present study includes 77.4% of women and 22.6%
of men aged 20–87 years and free of hypertension at
baseline. During the approximately 7 years between the
baseline and follow-up assessments, 16.4% of women
and 31.9% of men became hypertensive. The median
intake of Mg was 308 mg/day. Baseline characteristics
(sociodemographics, body composition, clinical parameters,
and dietary information, standardized by age and sex), areTable 1 Baseline characteristics across categories of magnesiu
Characteristics Magnesium intake
T1 (n = 459)
Age (years)b 40.7 (15.1)
Sex (% women) 76.0
Body mass index (kg/m2)b 25.4 (4.1)
Waist circumference (cm)b 87.7 (11.1)











Alcohol consumption (mg/day)b 3.9 (1.3)
Physical activity (METs/week)b 146.1 (66.1)
Postmenopausal hormones (current user)c 29.9
Multivitamin use (current user)c 37.0
History of hyperlipidemiac 15.0
Diabetes mellitusc 6.0
Total caloric intake (kcal/day)b 2,143 (148)
Glycemic loadb 201 (16.2)
Total fat intake (g/day)b 74.0 (32.6)
Total protein intake (g/day)b 95.2 (38.8)
Total cholesterol (mg/day) 297.7 (93.2)
Sodium intake (mg/day)b 2497 (850)
Fiber intake (g/day)b 14.4 (6.1)
Magnesium intake (mg/day)d 336.2 (223.2–381.1)
All variables have been analyzed after adjustment for age (5-year categories) and sex.
aANOVA test was used for quantitative variables; χ2 test was used for qualitative va
bValues are presented as means and SD (in parentheses).
cValues are presented as proportions.
dValues are presented as means and interquartile range (in parentheses).shown in Table 1 for the sample used in the incident
hypertension analysis. The highest tertile of magnesium
intake had a higher proportion of men, and subjects in
that tertile were slightly older and were less likely to be
current smokers, to exercise, or to take multivitamins or
postmenopausal hormones than those in the lowest
tertile of Mg consumption. Mg intake was also inversely
associated with intake of fat and cholesterol and positively
associated with the consumption of fiber and glycemic
load (Table 1).
Table 2 lists the results of a multivariate GEE analysis
evaluating the effects of Mg intake on systolic and diastolicm intake in adults of the Health Worker Cohort Study
P valuea
T2 (n = 459) T3 (n = 460)
41.7 (14.7) 41.9 (15.2) 0.451
76.5 73.2 0.473
25.5 (4.4) 25.5 (4.4) 0.583










4.2 (1.3) 4.1 (1.3) 0.103





2,135 (144) 2,138 (147) 0.675
303 (10.1) 464 (11.0) <0.001
52.1 (21.6) 46.9 (21.4) <0.001
69.4 (25.5) 63.4 (22.9) <0.001
219.5 (63.7) 201.1 (64.6) <0.001
1783 (581) 1615 (589) <0.001
16.6 (6.3) 19.2 (6.8) <0.001
359.3 (266.9–419.3) 420.6 (322.4–522.2) <0.001
All covariate values are listed according to the tertile of total magnesium intake.
riables.
Table 2 Coefficients of multiple GEE analysis for diastolic and systolic blood pressure after adjusting for potential
confounding variables
Outcomes Total magnesium intake (tertiles) P valuee
T1 T2 T3
β (95% CI) β (95% CI) β (95% CI)
Diastolic blood pressure (mmHg)a 0.0 −0.75 (−1.77, 0.27) −1.27 (−2.73, −0.02) 0.01
Systolic blood pressure (mmHg)a 0.0 −0.23 (−1.62, 1.07) −0.70 (−2.04, 0.65) 0.31
Diastolic blood pressure (mmHg)b 0.0 −0.72 (−1.71, 1.34) −1.11 (−4.38, 0.03) 0.05
Systolic blood pressure (mmHg)b 0.0 −0.20 (−1.57, 1.18) −0.47 (−1.86, 0.92) 0.50
Diastolic blood pressure (mmHg)c 0.0 −0.68 (−1.76, 0.41) −1.16 (−2.40, 0.07) 0.06
Systolic blood pressure (mmHg)c 0.0 −0.08 (−1.50, 1.35) −0.40 (−2.03, 1.24) 0.64
Diastolic blood pressure (mmHg)d 0.0 −0.60 (−1.65, 0.45) −1.12 (−2.31, 0.08) 0.06
Systolic blood pressure (mmHg)d 0.0 −0.01 (−1.35, 1.35) −0.35 (−1.92, 1.21) 0.66
aAdjusted for age (years), sex, and time.
bFurther adjusted for physical activity (METs/week), postmenopausal hormone use (yes/no), multivitamin use (yes/no), alcohol consumption (non-drinker/drinker),
smoking (never, past, and current).
cMultivariate model additionally adjusted for dietary intakes of saturated fat (g/day), cholesterol (mg/day), glycemic load (quintiles), sodium intake (mg/day), fiber
(g/day), and total energy (kcal/day).
dA full model with additional adjustment for body mass index (kg/m2), history of diabetes, and family history of hypertension.
eTest for linear trend.
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we found an inverse and significant relationship between
magnesium intake and diastolic blood pressure, with β
[95% confidence interval (CI)] comparing the top versus
the bottom tertiles of −1.27 mmHg (−2.73, −0.02; P
for linear trend = 0.01). A weak negative coefficient
was observed between magnesium intake and systolic
blood pressure, but this relationship was not statistically sig-
nificant (β=−0.70; 95% CI =−2.04, 0.65; P for linear trend
= 0.31). Comparing the highest and lowest tertiles of magne-
sium consumption, in the fourth model (adjusted for age,
sex, physical activity, postmenopausal hormone use, multi-
vitamin use, alcohol consumption, smoking, body mass
index, history of diabetes, and dietary intake of satu-
rated fat, cholesterol, glycemic load, sodium intake, fiber,
and total energy), the inverse relationship between magne-
sium intake and diastolic blood pressure was attenuated
and was not statistically significant (β = −1.12; 95% CI =
−2.31, 0.08; P for linear trend = 0.06). Finally, in the full
model (which also included body mass index, history of
diabetes, and family history of hypertension), we found an
inverse, but not significant relationship between magne-
sium intake and systolic blood pressure (β = −0.35; 95%
CI = −1.92, 1.21; P for linear trend = 0.66).
Table 3 shows the ORs and 95% CIs of multiple GEE ana-
lysis for incident hypertension. The multiple GEE models
reveal that magnesium intake was inversely associated with
risk of hypertension, but not significantly (P for linear
trend = 0.48). After adjustment for major confounders, we
observed a negative association with an OR of 0.83 (95%
CI = 0.49–1.39) when we compared the subjects with the
lowest level of magnesium intake (T1) and subjects in
the highest level of magnesium intake (T3).Discussion
In the present prospective cohort study with an approxi-
mately 7-year period of follow-up, we found a modestly
decreasing trend of diastolic blood pressure according to
higher amount of magnesium intake. However, our results
suggest no significant association between dietary magne-
sium intake and the subsequent development of hyperten-
sion in this adult Mexican population.
The relationship between magnesium and blood pressure
has been studied for decades. Many observational studies
have found an inverse association between magnesium
consumption and blood pressure, but this relationship is
not conclusively supported. Numerous cross-sectional
studies have linked dietary magnesium intake to lower
prevalence of hypertension [17,18], with most, but not all,
finding negative associations between magnesium intake
and blood pressure, although the cross-sectional associ-
ation appears to be consistent, given the characteristics of
this study design that finding does not necessarily imply a
causal relationship.
Evidence from prospective cohort studies has been
inconsistent [15,20,21,35-37]. For example, in the US, in
a 10-year follow-up study, Song et al. [20] found that
subjects in the highest quintile of magnesium intake had
a decreased risk for hypertension (relative risk = 0.91,
95% CI: 0.83–0.99, P for linear trend = 0.002) compared
with subjects in the lowest quintile. In contrast, our
findings are consistent with those from the Health
Professionals Follow-up Study conducted by Ascherio et al.
[36] and the Atherosclerosis Risk in Communities Study
done by Peacock et al. [21], which found weak and non-
significant associations between magnesium consumption
and hypertension. In general, available evidence from
Table 3 Odds ratios of multiple GEE analysis for incident hypertension after adjusting for potential confounding
variables
Outcomes Total magnesium intake (tertiles) P valuee
T1 T2 T3
OR (95% CI) OR (95% CI) OR (95% CI)
Hypertension (model 1)a 1.0 0.91 (0.60–1.38) 0.85 (0.55–1.30) 0.46
Hypertension (model 2)b 1.0 1.0 (0.65–1.58) 0.93 (0.51–1.44) 0.76
Hypertension (model 3)c 1.0 1.0 (0.64–1.58) 0.86 (0.51–1.44) 0.57
Hypertension (model 4)d 1.0 0.99 (0.63–1.57) 0.83 (0.49–1.39) 0.48
Hypertension: systolic blood pressure ≥140 mmHg or/and diastolic blood pressure ≥90 mmHg.
aAdjusted for age (years), sex, and time.
bFurther adjusted for physical activity (METs/week), postmenopausal hormone use (yes/no), multivitamin use (yes/no), alcohol consumption (non-drinker/drinker),
smoking (never, past and current).
cMultivariate model additionally adjusted for dietary intakes of saturated fat (g/day), cholesterol (mg/day), glycemic load (quintiles), sodium intake (mg/day),
fiber (g/day), and total energy (kcal/day).
dA full model with additional adjustment for body mass index (kg/m2), history of diabetes, and family history of hypertension.
eTest for linear trend.
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intake plays a primary role in the prevention of hyperten-
sion, although the possibility that high magnesium intake
has a minor effect in reducing blood pressure in normoten-
sive subjects should not be ruled out. Although some
cohort studies have found lack of association between
dietary magnesium intake and the risk of hypertension,
there has been recent interest in magnesium therapy as a
method to reduce blood pressure. However, clinical
evidence for blood pressure reduction with magnesium
supplementation remains equally unclear [24-26]. A recent
meta-analysis of 22 clinical trials suggests a negative associ-
ation between magnesium supplementation and diastolic
and systolic blood pressure; these trials found an average
reduction of 2–3 mmHg for diastolic blood pressure and
3–4 mmHg for systolic blood pressure [38].
In order to understand the lack of association between
dietary magnesium intake and the subsequent development
of hypertension in this adult Mexican population, some
limitations of the present cohort should be considered.
Some of these limitations relate to the measurement of
nutrient consumption and effects. First, errors in the
measurement of self-reported dietary intake are inevitable.
However, because the data were prospectively collected, the
misclassification of dietary intake was likely to be non-
differential and could have led to an underestimation of the
association between dietary magnesium intake and the risk
of hypertension in our study. Additionally, these errors are
unlikely to affect our results, since the FFQ that we used in
this study has been validated [31] as reasonably reflecting
long-term dietary intake. Second, there is a high degree of
multicolinearity among magnesium and several other nutri-
ents that makes it difficult to completely separate the inde-
pendent effects of magnesium from those of nutrients like
fiber, sodium, potassium, folate, and calcium. Third, in our
cohort, we observed a relatively narrow range of mag-
nesium intake, which could limit our ability detect amoderate association between magnesium intake and
blood pressure. Fourth, while the prospective design of
our study reduces the possibility of recall or selection bias,
the low response rate at follow-up and the small sample
size may have influenced our results, which were not
statistically significant.
Other study limitations relate to possible confounding
of data. First, the participants might have changed their
diets after developing disease, leading to a conservative
estimate of the relationship between magnesium and
blood pressure. However, this is unlikely since the model
that excluded participants who had histories hypertension
or dyslipidemia generated null associations similar to
other models. Second, we did not separately compare the
effects of dietary magnesium and supplementary magne-
sium, but since subjects’ intake of magnesium from
supplements was minor compared with dietary intake, this
was not likely to have influenced the results. Finally, while
we adjusted for potential confounding factors, the
possibility of residual or unmeasured confounds still
remains. In addition, the participants in this cohort study
are adults from a specific segment of the Mexican popula-
tion: working class, seemingly healthy individuals. While
they cannot be considered representative of the Mexican
adult population as a whole, they may be considered
representative of middle- to low-income adults residing in
the urban areas of central Mexico.Conclusions
In conclusion, these results do not support the hypothesis
that magnesium intake reduces the development of
hypertension, although a modest inverse association with
blood pressure cannot be ruled out.
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